Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2023, năm kết thúc ngày Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics cash
Cash and short-term investments held at the end of each period.
Medicenna Therapeutics's cash was C$33.60M at Mar 31, 2023. For fiscal 2023 it was C$33.60M, up 63.6% from the year before. The highest annual figure on record is C$33.60M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | C$33.60M | +63.6% |
| FY2022 | Mar 31, 2022 | C$20.54M | -32.4% |
| FY2021 | Mar 31, 2021 | C$30.38M | +33.8% |
| FY2020 | Mar 31, 2020 | C$22.70M | +857.3% |
| FY2019 | Mar 31, 2019 | C$2.37M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | C$33.60M | +10.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | C$20.54M | -9.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | C$20.54M | -9.5% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | C$30.38M | +1181.1% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | C$30.38M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | C$22.70M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | C$22.70M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | C$2.37M | – |
See a number that looks wrong?